Michael R Rickels1, Rebecca Mueller, James F Markmann, Ali Naji. 1. Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Pennsylvania School of Medicine, 700 Clinical Research Building, 415 Curie Boulevard, Philadelphia, Pennsylvania 19104-6149, USA. rickels@mail.med.upenn.edu
Abstract
CONTEXT: Glucose-dependent insulin secretion is often impaired after islet transplantation where reduced beta-cell secretory capacity indicates a low functional beta-cell mass. OBJECTIVE: We sought to determine whether glucagon-like peptide-1 (GLP-1) enhanced glucose-dependent insulin secretion and glucagon suppression in islet recipients, and whether GLP-1 effects were dependent on functional beta-cell mass by simultaneously studying recipients of whole pancreas transplants. SETTING: The study was performed in a clinical and translational research center. PARTICIPANTS: Five intraportal islet and six portally drained pancreas transplant recipients participated in the study. INTERVENTION: Subjects underwent glucose-potentiated arginine testing with GLP-1 (1.5 pmol . kg(-1) . min(-1)) or placebo infused on alternate randomized occasions, with 5 g arginine injected under basal and hyperglycemic clamp conditions. RESULTS:Basal glucose was lower with increases in insulin and decreases in glucagon during GLP-1 vs. placebo in both groups. During the hyperglycemic clamp, a significantly greater glucose infusion rate was required with GLP-1 vs. placebo in both groups (P < 0.05), an effect more pronounced in the pancreas vs. islet group (P < 0.01). The increased glucose infusion rate was associated with significant increases in second-phase insulin secretion in both groups (P < 0.05) that also tended to be greater in the pancreas vs. islet group (P = 0.08), whereas glucagon was equivalently suppressed by the hyperglycemic clamp during GLP-1 and placebo infusions in both groups. The GLP-1-induced increase in second-phase insulin correlated with the beta-cell secretory capacity (P < 0.001). The proinsulin secretory ratio (PISR) during glucose-potentiated arginine was significantly greater with GLP-1 vs. placebo infusion in both groups (P < 0.05). CONCLUSIONS: GLP-1 induced enhancement of glucose-dependent insulin secretion, but not glucagon suppression, in islet and pancreas transplant recipients, an effect dependent on the functional beta-cell mass that may be associated with depletion of mature beta-cell secretory granules.
RCT Entities:
CONTEXT: Glucose-dependent insulin secretion is often impaired after islet transplantation where reduced beta-cell secretory capacity indicates a low functional beta-cell mass. OBJECTIVE: We sought to determine whether glucagon-like peptide-1 (GLP-1) enhanced glucose-dependent insulin secretion and glucagon suppression in islet recipients, and whether GLP-1 effects were dependent on functional beta-cell mass by simultaneously studying recipients of whole pancreas transplants. SETTING: The study was performed in a clinical and translational research center. PARTICIPANTS: Five intraportal islet and six portally drained pancreas transplant recipients participated in the study. INTERVENTION: Subjects underwent glucose-potentiated arginine testing with GLP-1 (1.5 pmol . kg(-1) . min(-1)) or placebo infused on alternate randomized occasions, with 5 g arginine injected under basal and hyperglycemic clamp conditions. RESULTS: Basal glucose was lower with increases in insulin and decreases in glucagon during GLP-1 vs. placebo in both groups. During the hyperglycemic clamp, a significantly greater glucose infusion rate was required with GLP-1 vs. placebo in both groups (P < 0.05), an effect more pronounced in the pancreas vs. islet group (P < 0.01). The increased glucose infusion rate was associated with significant increases in second-phase insulin secretion in both groups (P < 0.05) that also tended to be greater in the pancreas vs. islet group (P = 0.08), whereas glucagon was equivalently suppressed by the hyperglycemic clamp during GLP-1 and placebo infusions in both groups. The GLP-1-induced increase in second-phase insulin correlated with the beta-cell secretory capacity (P < 0.001). The proinsulin secretory ratio (PISR) during glucose-potentiated arginine was significantly greater with GLP-1 vs. placebo infusion in both groups (P < 0.05). CONCLUSIONS:GLP-1 induced enhancement of glucose-dependent insulin secretion, but not glucagon suppression, in islet and pancreas transplant recipients, an effect dependent on the functional beta-cell mass that may be associated with depletion of mature beta-cell secretory granules.
Authors: Niraj M Desai; John A Goss; Shaoping Deng; Bryan A Wolf; Eileen Markmann; Maral Palanjian; Angela P Shock; Sue Feliciano; F Charles Brunicardi; Clyde F Barker; Ali Naji; James F Markmann Journal: Transplantation Date: 2003-12-15 Impact factor: 4.939
Authors: Charlotte G McDonald; Edmond A Ryan; Breay W Paty; Peter A Senior; Sally M Marshall; Jonathan R T Lakey; A M James Shapiro Journal: Transplantation Date: 2004-09-27 Impact factor: 4.939
Authors: Adam Frank; Shaoping Deng; Xiaolun Huang; Ergun Velidedeoglu; Yong-Suk Bae; Chengyang Liu; Peter Abt; Robert Stephenson; Muhammad Mohiuddin; Thav Thambipillai; Eileen Markmann; Maral Palanjian; Marty Sellers; Ali Naji; Clyde F Barker; James F Markmann Journal: Ann Surg Date: 2004-10 Impact factor: 12.969
Authors: Chuan-an Shen; Shawn Fagan; Alan J Fischman; Edward E Carter; Jia-Ke Chai; Xiao-Ming Lu; Yong-Ming Yu; Ronald G Tompkins Journal: Surgery Date: 2011-02-05 Impact factor: 3.982
Authors: E Favaro; R Granata; I Miceli; A Baragli; F Settanni; P Cavallo Perin; E Ghigo; G Camussi; M M Zanone Journal: Diabetologia Date: 2012-01-10 Impact factor: 10.122
Authors: Andrea Kelly; Saba Sheikh; Darko Stefanovski; Amy J Peleckis; Sarah C Nyirjesy; Jack N Eiel; Aniket Sidhaye; Russell Localio; Robert Gallop; Diva D De Leon; Denis Hadjiliadis; Ronald C Rubenstein; Michael R Rickels Journal: J Clin Endocrinol Metab Date: 2021-05-22 Impact factor: 5.958
Authors: Makoto Shigeto; Reshma Ramracheya; Andrei I Tarasov; Chae Young Cha; Margarita V Chibalina; Benoit Hastoy; Koenraad Philippaert; Thomas Reinbothe; Nils Rorsman; Albert Salehi; William R Sones; Elisa Vergari; Cathryn Weston; Julia Gorelik; Masashi Katsura; Viacheslav O Nikolaev; Rudi Vennekens; Manuela Zaccolo; Antony Galione; Paul R V Johnson; Kohei Kaku; Graham Ladds; Patrik Rorsman Journal: J Clin Invest Date: 2015-11-16 Impact factor: 14.808